- Report
- October 2023
- 80 Pages
Germany
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 80 Pages
France
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 80 Pages
China
From €1328EUR$1,500USD£1,150GBP
- Report
- July 2023
- 223 Pages
Global
From €3984EUR$4,500USD£3,451GBP
- Report
- September 2022
- 39 Pages
Global
From €1771EUR$2,000USD£1,534GBP
- Report
- October 2023
- 80 Pages
Russia
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 80 Pages
Poland
From €1328EUR$1,500USD£1,150GBP
Liothyronine is a synthetic form of the thyroid hormone triiodothyronine (T3). It is used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. It is also used to treat goiter, an enlarged thyroid gland, and to treat thyroid cancer. Liothyronine is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders.
Liothyronine is available in both brand-name and generic forms. It is available as a tablet, capsule, and liquid solution. It is usually taken once a day, but the dosage and frequency may vary depending on the patient's condition.
Companies in the Liothyronine market include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more
